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ABSTRACT  The  possible role of a  140-kD cell  surface complex  in  neural crest adhesion and 
migration  was examined  using a  monoclonal  antibody  JG22,  first  described  by  Greve  and 
Gottlieb  (1982, J.  Cell.  Biochem.  18:221-229).  The addition  of JG22  to  neural  crest cells  in 
vitro  caused a rapid  change  in  morphology  of cells  plated  on either  fibronectin  or laminin 
substrates. The cells became round and phase bright, often detaching from the dish or forming 
aggregates of rounded cells. Other tissues such as somites, notochords, and neural tubes were 
unaffected  by the antibody in vitro even though the JG22 antigen is detectable in embryonic 
tissue sections on the surface of the myotome,  neural tube, and notochord. The effects of the 
JG22  on  neural  crest  migration  in  vivo  were examined  by a  new perturbation  approach  in 
which  both  the  antibody  and  the  hydridoma  cells  were  microinjected  onto  neural  crest 
pathways. Hybridoma cells were labeled with a fluorescent cell marker that is nondeleterious 
and that is preserved after fixation  and tissue sectioning. The JG22 antibody and hybridoma 
cells caused a marked  reduction  in  cranial  neural crest migration,  a build-up of neural crest 
cells within the lumen of the neural tube, and some migration along aberrant pathways. Neural 
crest migration  in the trunk was affected  to a much  lesser  extent.  In  both  cranial  and trunk 
regions, a cell free zone of one or more cell diameters was generally observed between neural 
crest  cells  and  the  JG22  hybridoma  cells.  Two other  monoclonal  antibodies,  1-B and  l-N, 
were used as controls.  Both  1-B and  1-N  bind to bands of the  140-kD complex  precipitated 
by  JG22.  Neither  control  antibody  affected  neural  crest  adhesion  in  vitro  or  neural  crest 
migration  in situ. This suggests that the observed alterations in neural crest migration are due 
to a functional  block of the 140-kD complex. 
Several important developmental events are accompanied by 
temporal or spatial changes in the composition of the extra- 
cellular matrix (ECM). ~ For example, hyaluronate accumu- 
lates in the corneal stroma during the invasion of the corneal 
fibroblast and is subsequently removed by increased produc- 
tion of hyaluronidase (25).  Fibronectin has been implicated 
in guiding cell movement during gastrulation (1) and neural 
crest migration (10, 24) because it lines pathways followed by 
migrating cells.  Such  correlations have led to  the  proposal 
that  adhesive interactions  between  the  extracellular matrix 
and the embryonic cell surface may play an important role in 
morphogenesis (13). 
The neural crest is an interesting model for examining the 
role  of cell  surface-ECM  interactions  because  these  cells 
migrate extensively during development along pathways that 
Abbreviations  used in this paper. CFSE, carboxyfluorescein  diacetate 
suecinimyl ester; ECM, extracellular matrix. 
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are lined with ECM molecules. Neural crest cells arise during 
neurulation  and depart from the newly formed neural tube 
shortly after tube closure. The pathways followed by neural 
crest cells contain  numerous matrix molecules including fi- 
bronectin,  hyaluronic  acid,  type  I  collagen,  and  probably 
various other molecules. In tissue culture, neural crest cells 
can migrate in a directed fashion along fibronectin rich mat- 
rices (22) and can also migrate on laminin (17). When trans- 
planted into premigratory regions of axolotl embryos, micro- 
carrier  filters  coated  with  embryonic  matrices  from  older 
embryonic  regions  can  promote  premature  migration  of 
neural crest cells (14).  These studies indicate that the ECM 
may  be  both  permissive  and  stimulatory  for  neural  crest 
migration. 
Recently,  several  monoclonal  antibodies  were  described 
that recognize cell surface proteins involved in adhesion ( l l, 
16, 20).  Two of these monoclonals, called JG22 and CSAT, 
perturb  the  adhesion  of embryonic  muscle  cells  to  some 
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same antigen, a  140-kD complex of proteins localized in the 
region of cell-substratum attachment (6,  1 l,  16).  The  140- 
kD complex  has recently been  shown to co-distribute with 
both a-actinin and flbronectin, which suggests that the anti- 
gens may represent a cell surface linkage between ECM mol- 
ecules and the cytoskeleton (6). 
In this study I examined some effects of the monoclonal 
antibody JG22  on neural crest cells in vitro and in vivo. To 
test the effects of JG22 in vivo, a novel perturbation approach 
has been developed  in  which antibody-containing medium 
together with  the  hybridoma cells  themselves are  microin- 
jected onto neural crest pathways. The hybridoma cells are 
labeled by a new fluorescent staining method that renders the 
cells identifiable in living preparations and histologically proc- 
essed tissue sections. Both in tissue culture and in the embryo, 
JG22 affects the adhesion and migration of neural crest cells. 
In contrast, two other monoclonal antibodies,  I-B and  I-N, 
that bind  to bands of the  140-kD complex precipitated by 
JG22,  affect neither cell adhesion or neural crest migration. 
The results suggest that the adhesive interaction blocked by 
JG22 is important for normal neural crest migration. 
MATERIALS  AND  METHODS 
Neural Crest Cultures 
Primary cultures of neural crest cells were prepared from the neural tubes 
of Japanese quail embryos (coturnix coturnix japonica) (7, 8).  Embryos were 
incubated  for  48  h  at  38"C,  at  which  time  their  developmental age  was 
comparable to chick stages 13-15 (12).  The region of the trunk consisting of 
the six to nine most recently formed somites and some unsegmented mesen- 
chyme was dissected away from the embryo. The neural tubes were isolated 
from surrounding tissues by proteolytic digestion with 150 U/ml of collagenase 
(CLS I1; Cooper Biomedical Inc., Malvern, PA) for  15 min at 4"C and for an 
additional 6-9 minutes at 37'C. The reaction was stopped with complete tissue 
culture medium of Eagle's minimum essential medium containing 15% horse 
serum and  10%  chick embryo extract, since the serum components contain 
endogenous protease inhibitors. The  isolated neural tubes,  with notochords 
sometimes attached to the ventral surface, were rinsed in complete medium 
and then plated onto fibronectin- or laminin-coated substrates. After 2-3 h, 
neural crest cells begin migrating away from the dorsal aspect of the neural 
tube and  form  a  monolayer of cells on the culture dish. At this time, the 
cultures were fed complete medium (Eagle's minimum essential medium, 10% 
embryo extract,  15% horse serum). In some cases, Eagle's minimum essential 
medium, a defined medium lacking serum and embryo extract, was substituted 
for  complete  medium  during  rinsing,  plating, and  feeding of the  cells to 
eliminate any possible effects of serum or embryo extract components. Most 
cultures were used  for  adhesion assays 24  h  after plating. In those cultures 
maintained for longer periods,  neural  tubes were scraped away after 24  h, 
leaving a monolayer of neural crest cells. Cultures were fed fresh medium every 
other day. For some experiments, somites isolated in the same manner as the 
neural tubes described above were plated onto fibronectin- or laminin-coated 
substrates. 
Attachment of Extracellular Matrix Molecules to 
Tissue Culture Plates 
To prepare fibronectin substrates, 35-mm petri plates were incubated with 
25 ~g/ml of fibronectin (Meloy Laboratories. Inc., Springfield, VA) in phos- 
phate-buffered  saline (PBS)  for  l0  min.  After  removal  of the  fibronectin 
solution, the plates were air-dried.  Laminin-coated dishes were prepared by 
incubating the petri dishes with 0.5 mg/ml poly-D-lysine for 30 min at 37"C; 
the plates were washed four times with PBS and then incubated overnight with 
20  #g/ml  of laminin (kindly provided  by  Dr.  L.  Reichardt,  University of 
California, San  Francisco, CA).  Before plating of neural tubes,  the laminin 
solution was removed and the plates were washed with PBS. 
Hybridoma Cells 
JG22 hybridoma cells were kindly provided by Dr. David Oottlieb (Wash- 
ington University, St. Louis, MO). I-B and t-N hybridoma cells were agenerous 
gift from Dr. Clayton Buck (Wistar Institute, Philadelphia, PA). The cells were 
maintained in 75- or 250-mr tissue culture flasks in Dulbecco's modified eagle's 
medium containing 15% fetal bovine serum. 
Labeling of Hybridoma Cells 
Both 5- and 6-carboxyfluorescein diacetate succinimyl ester and fluorescein- 
5-isothiocyanate diacetate (Molecular Probes Inc., Junction City, OR)  were 
used to vitally  dye cells. These dyes remain visible within the cells after fixation, 
paraffin embedding, and serial sectioning. Most experiments were performed 
with carboxyfluorescein diacetate succinimyl ester (CFSE) because this proved 
to  be the more intense and  long-lived marker.  A  10  mM  stock solution of 
CFSE was prepared in dimethy| sulfoxide and stored at 4*C. For cell labeling, 
the CFSE working solution was prepared by diluting the stock solution 1:300 
in  PBS,  pH  7.4.  Hybridoma  cells were  centrifuged and  the  medium  was 
removed. The cells were then suspended in CFSE working solution and incu- 
bated  at  37"C  for  30  min.  The  labeled hybridoma ceils were centrifuged, 
resuspended in medium containing antibodies, and microinjected into embryos. 
Concentration of Antibodies 
The culture medium was removed from the hybridoma cells and placed in 
Amicon microcentricon filters with a  30,000-mol-wt cut-off (Amicon Corp., 
Scientific Systems Div.,  Danvers,  MA).  The  medium containing the mouse 
lgG's was centrifuged at 4,800 g for 2-3 h. This procedure yielded a 20-30 fold 
concentration of antibody in the retentate. 
Preparation of the Host 
White leghorn chicken embryos were incubated at 38"C. Embryos at devel- 
opmental stages 8-10 were used for injections into the mesencephalic region, 
and those at stages 12-15  for injections in the trunk. The eggs were washed 
with  70%  ethanol,  windowed,  and  stained with  an  injection  of India  ink 
(Pelikan, Hanover, FRG) under the blastodisk (23).  The vitelline membrane 
was removed over the injection site. After injection, the embryo was closed 
with adhesive tape and returned to the incubator until the time of fixation. 
Microinjection of Antibody and Hgbridoma Cells 
into Chick Embryos 
Microinjections were performed using a previously described injection tech- 
nique (3,  4).  The hybridoma cells and the antibody containing medium were 
backfilled into fine glass micropipettes. The tip of the pipette was broken off to 
produce  an  opening  of  20-30-~m  diam.  The  injection  micropipette  was 
mounted on the electrode carrier of a micromanipulator and connected to an 
air pressure source. The manipulator was then used to insert the micropipette 
into the appropriate embryonic site, either lateral to  the neural tube in the 
mesencephalon or into the embryonic somites in the trunk. The hybridoma 
cells and antibodies were expelled with a  pulse of pressure and the injection 
needle was withdrawn. Approximately 4 nl was injected into the mesencephalic 
region, and -0.5 nl into the trunk somites. 
Histological Procedures 
PARAFFIN  SECTIONS:  Embryos were fixed for 2 h  in Zenker's fixative 
and placed first into running water for 2  h,  and then into 70% ethanol. The 
embryos were dehydrated, embedded in paraplast, and serially sectioned at 10 
~m. Sections were mounted on albuminized slides and dried for several hours 
before antibody staining. 
CRYOSTAT  SECTIONS:  Embryos were fixed in 4% paraformaldehyde in 
PBS (pH 7.4) for 1.5 h, rinsed in PBS, and dehydrated through a graded series 
of ethanols. Embryos were then placed in absolute ethanol for 48 h.  In some 
cases, the paraformaldehyde fixation were omitted and embryos were placed 
directly into ethanol. The embryos were hydrated in PBS and placed first into 
5% sucrose containing 0.01% azide for 2-4 h and then into 15 % sucrose at 4"C 
overnight. They were placed in 7.5% gelatin/15% sucrose solution at 37*C for 
2-3 hours, oriented, and frozen in Tissue Tek OCT (Miles Laboratories Inc., 
Elkhart, IN) in liquid nitrogen. Frozen sections were cut at 10 um on an A/O 
Histostat Cryostat (Reichardt Scientific Instruments, Buffalo, NY). 
Immunofluorescent Staining 
Slides were scanned  for  fluorescently labeled hydridoma cells which are 
readily visible under epifiuorescent illumination within paraffin sections. The 
sections containing hybridoma cells and neighboring sections were then stained 
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is a mouse lgM that stains migrating avian neural crest cells, as well as neurons, 
glia, and a subpopulation of leukocytes (26). The cell surface antigen recognized 
by HNK-I  is the same antigen recognized by NC-I  (26).  The sections were 
deparaffinized in histosol, taken through a graded series of alcohols, and placed 
into PBS. They were then incubated with HNK- 1 (diluted 1:30) in a humidified 
chamber at room temperature overnight. The slides were washed in PBS and 
incubated with a rabbit antibody against mouse IgM's for I h at room temper- 
ature. The sections were then washed and incubated with a fluorescein-conju- 
gated goat antibody against rabbit IgG's. After sections were rinsed in PBS,  a 
few drops of fresh PBS were added; the slides were covered with coverslips and 
observed under a Zeiss epifluorescence microscope. 
Because JG22 is an IgG whereas HNK-I  is an lgM, it is possible to perform 
double labeling experiments using differently labeled second antibodies. Cryo- 
slat sections of chick embryos were prepared. Sections were incubated overnight 
in a humified chamber with medium containing JG22 and with HNK- I (1:30). 
The sections were washed in PBS,  incubated with a rabbit anti-mouse IgM for 
1 h, washed, and stained with rhodamine-conjugated goat antibodies against 
mouse  lgG (1:25)  and  fluorescein-conjugated goat antibodies against rabbit 
lgG's. After they were rinsed and covered with coverstips, sections were observed 
under epifluorescent illumination. Data were recorded photographically and 
on videotapes using a  Silicon Intensified Target (SIT; RCA,  Lancaster,  PA) 
image intensifying video camera and a video recorder. 
Quantitative Analysis of Neural Crest Inhibition 
To  quantitate the  volume occupied by  neural  crest cells, serial sections 
through the injected embryos were examined under the fluorescence micro- 
scope. Those areas containing neural crest cells could be recognized by their 
HNK-I  fluorescence. The main site of injection was easily identifiable since it 
contained the highest concentration of hybridoma cells. Videotape recordings 
were made of sections throughout the mesencephalon anterior and posterior to 
the injection site, or through one or more somites anterior and posterior to the 
injection site in the trunk.  To quantitate the effects of JG22 on neural crest 
migration, tracings that outlined the area occupied by neural crest cells were 
prepared  off of the  video screen  for  every section  along -220  um  of the 
anterior-posterior extent of the embryo centered on  the injection site. The 
surface area of each tracing was determined using an Orthoplex Coordinate 
Sensor Type 3825-1  (Elographics Inc., Oakridge, TN) and a Wang series 600 
computer (Wang Laboratories, Inc., Lowell, MA). For each side of the embryo, 
the surface areas from all tracings were summed. Because the volume equals 
the surface area times the section thickness, the ratio of the summed  areas 
reflects the fraction of the volume occupied by neural crest cells on the injected 
versus the control side. 
RESULTS 
JO22 is an antibody made against chick skeletal muscle cells 
(11) that recognizes a cell surface molecule involved in muscle 
cell attachment to tissue culture substrates.  In the presence of 
the  antibody,  muscle  cells  undergo  rapid  changes in  mor- 
phology and sometimes detach from the substrate,  whereas 
fibroblasts in the same cultures remain unaffected.  The effects 
of JG22 on neural crest  adhesion in vitro and  neural crest 
migration in vivo are described  below. 
Effects of JG22 Antibody on Neural Crest 
Cells In Vitro 
Neural crest cell cultures were prepared from quail neural 
primordia  as  described  (see Materials  and  Methods)  and 
plated onto fibronectin or laminin-coated petri dishes.  The 
culture  medium  was  removed and  replaced  with  medium 
conditioned by JG22 hybridoma ceils. Control cultures were 
fed either medium alone (Dulbecco's modified Eagle's  me- 
dium plus  15%  fetal  bovine serum) or medium containing 
the  I-B or  1-N  control antibodies.  The control antibodies 
bind to bands  1 and 3, respectively,  in the  140-kD complex 
recognized by JG22 and CSAT (Buck, C., personal  commu- 
nication).  Neural  crest  cells  are  typically grown  in  a  rich 
culture medium containing horse serum and embryo extract. 
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For some  experiments,  neural  crest  cells were  plated  and 
grown in medium without serum or embryo extract to elim- 
inate  any possible  contributions of horse serum or embryo 
extract  components to the tissue culture substrate.  Identical 
results were observed in both types of media. 
JG22 antibodies caused rapid and profound changes in the 
morphology of neural  crest  cells  grown  on  fibronectin  or 
laminin substrates.  In neural crest cultures  24 h after plating, 
most neural crest cells rounded up and became phase bright 
within minutes after addition of the antibody (Fig.  1). Some 
of the rounded cells detached from the dish, whereas  others 
remained tenuously attached.  In addition, many neural crest 
cells tended  to  form small  aggregates.  Similar  effects  were 
observed in cultures of various ages ranging from 6 h to 8 d 
after plating.  In contrast, other cell types such as neural tube 
cells, notochord cells, or somite cells included on the same 
culture dish underwent little or no morphological change.  In 
some cases, the edges of the epithelial  sheets  formed by the 
cultured neural tube cells did appear to roll up slightly. Cells 
in control cultures fed fresh culture medium, medium con- 
mining l-B, or medium containing 1-N antibodies  were un- 
perturbed. 
JC22 Antigen Is Present on Migrating 
Neural Crest Cells 
Cryostat sections  of chicken embryos were double labeled 
with JG22 antibody (a mouse IgG) and with HNK- 1 antibody 
(a mouse IgM). HNK- 1 was used to identify neural crest cells 
(26). JG22 antigen was detected on the surface of migrating 
neural crest  cells, in both the trunk and the mesencephalic 
re#on (Fig. 2). In addition, JG22 staining was present around 
the basal surface of  the neural tube, notochord, and myotome. 
A detailed description of the distribution pattern of the JG22 
antigen in early embryos will be described  elsewhere (Kroto- 
ski, D., E. Montgomery, and M. Bronner-Fraser,  manuscript 
in preparation).  It is interesting  that JG22 antibody did not 
cause detachment of neural tube, notochord, or somite cells 
from fibronectin or laminin substrates  in vitro. These results 
suggest that  these  tissues  may have some adhesive  mecha- 
nisms in addition to the antigen recognized by JG22. 
Labeling of JG22 Hybridoma Cells 
The purpose of injecting  hybridoma cells into the devel- 
oping embryos was twofold: to serve as a convenient marker 
for the site of injection and to provide a continuous source of 
antibody within the embryo. To allow the cells to be located 
after injection,  the hybridomas must be labeled with a marker 
that can survive the fixation  and embedding procedure used 
to analyze the data.  In addition, the dye must be nondeleter- 
ious to the function of  the hybridoma cells. Of the dyes tested, 
CFSE was found to stain the hybridoma cells intensely  both 
before  and  after  fixation  in  10%  buffered  formalin  or  in 
Zenker's fixative.  The CFSE  diffuses  freely  across  the  cell 
membrane, where  intracellular  esterases release the chroma- 
phore.  The negatively charged chromaphore is then retained 
within  the cell. The CFSE  remains within  the labeled  cells 
over long periods; one set of hybridoma cells was maintained 
in culture for 3 wk and still contained many fluorescent  cells. 
To assess the effects of CFSE labeling on antibody produc- 
tion, hybridoma cells were labeled  as described  in Materials 
and Methods, placed in fresh culture medium, and allowed FIGURE  1  Phase-contrast  photomicrographs illustrating the effects  of JG22 antibody on neural crest cells in vitro. (a)  A culture 
of neural crest cells grown on fibronectin 24 h after explantation of the neural tube (nt) onto the culture dish. The neural crest 
cells have emigrated from  the neural tube and  have formed a monolayer on the substrate.  (b)  The same field  15  min after 
addition of JG22 antibodies. Many cells have become rounded and phase bright, and often detach from the substrate; other cells 
form small aggregates. (c)  The same field after 60 min. More cells have detached or formed aggregates. Note that the neural 
tube does not appear to be affected, x  200. 
FtGURE  2  Fluorescence  photomicrographs of  a  cryostat section 
through the trunk of a 2.5-d chick embryo. (a)  Rhodamine immu- 
nofluorescence of JG22 staining,  x  880.  The JG22 antigen is seen 
on the basolateral  side of the neural tube (nt), the myotome (m), 
and on the surface  of neural crest cells  (nc). In addition, JG22 is 
detected around the notochord (not shown). (b)  The same section 
visualized through a fluorescein filter set shows HNK-1  staining of 
neural crest cells x  880. 
to proliferate for 24 h. The culture medium was then removed 
and tested for the presence of JG22 antibodies by an assay of 
its  effects  on  neural  crest  adhesion  in  vitro.  The  culture 
supernatant from the labeled cells caused rapid rounding and 
detachment of neural crest cells; these effects were identical 
in  morphology and  time  course  to  those  caused  by  JG22 
medium removed from unlabeled hybridoma cells. 
Effects of JG22 Antibody on Cranial 
Neural Crest Migration 
After they were labeled, hybridoma cells were resuspended 
in  either  fresh  medium  or  medium  that  contained  JG22 
antibody concentrated 20- to 30-fold. The antibody and cell 
suspension  was backfilled  into  a  micropipette  and  injected 
into  the  mesencephalon  during  the  early  stages  of cranial 
neural crest migration.  Each embryo was injected lateral  to 
the  mesencephalic  neural  tube  with  -4  nl cell  suspension. 
The embryos were allowed to develop from 4  to 22 h  after 
injection, fixed, sectioned, and stained with HNK-1 antibody 
to monitor the effects of the injection on neural crest migra- 
tion. The labeled hybridoma cells were easily detected in fixed 
and antibody-stained sections because the cells have round, 
brightly fluorescent cell bodies, which can be visualized with 
several different fluorescent filter sets. 
In an initial series of experiments,  the effects of the JG22 
hybridoma cells alone were examined;  10 embryos were in- 
jected with JG22 hybridoma cells plus fresh culture medium, 
without JG22 antibody. In one of these embryos, a reduction 
of neural crest migration was observed on the injected side 
relative to the control side. In the remaining embryos, few or 
no differences in cell  numbers were noted between injected 
and  control  sides;  however,  a  cell  free  zone  was  observed 
between the hybridoma cells and the neural crest cells.  In the 
case of JG22 hybridoma cells,  78 ___ 6%  (n =  6  embryos) of 
the  hybridoma cells were located at least  one cell diameter 
away from the closest neural  crest cell.  This is significantly 
higher (P <  0.025) than in control embryos, where only 31 ___ 
7%  (n =  3 embryos injected with  1-B hybridoma cells)  and 
41  +  25 (n =  5 embryos injected with  1-N hybridoma cells) 
were  one  or  more  cell  diameters  distant  from  the  nearest 
neural  crest  cell.  These  results  suggest  that  the  JG22  hy- 
bridoma cells usually affect neural crest cells  only at a  local 
level,  within a few cell diameters. 
In  a  second  series  of experiments,  hybridoma cells  were 
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tion  to  the  cell-free  space observed between  most injected 
JG22 hybridoma cells and the endogenous neural crest cells, 
profound alterations in neural crest migration were observed 
in 34 of the 41  embryos injected with JG22 antibodies (Fig. 
3). The amount of neural crest migration on the injected side 
appeared reduced.  The neural  crest cell  volume was deter- 
mined by measuring the area occupied by neural crest cells 
in each section through the mesencephalon in six randomly 
selected embryos. The volume on the injected side was re- 
duced by 54 ___ 5% in these animals relative to the noninjected 
side. Note that the calculated 54% reduction is summed over 
the entire mesencephalon and that  individual sections may 
have a  much  larger difference in  neural  crest cell  number 
between the injected and control side (Fig. 3 b). The decrease 
in  volume on the  injected  side probably reflects an  actual 
decrease in  numbers of neural  crest cells;  on both injected 
and control sides, neural crest cells migrate in close association 
to one another and  the size of individual cells  appears un- 
changed on the injected side. 
In addition to reduced cell  numbers, 9 of the 34 affected 
embryos had a  lobule containing HNK-1  positive cells pro- 
truding into the lumen of the neural tube (Fig.  3c).  Presum- 
ably, these stained cells are neural crest cells; HNK- 1 normally 
recognizes  neural  crest  cells  only after they  have departed 
from the neural tube. This build-up of neural crest cells may 
reflect some inhibition of normal crest emigration from the 
dorsal neural tube.  It is  interesting that the most profound 
alterations  in  neural  crest  migration  were  often  observed 
posterior to the main injection site (i.e.,  the region with the 
highest  concentration  of hybridoma  cells).  In  the  anterior 
regions,  many neural  crest cells  may have already left the 
neural tube at the time of injection. Perhaps the more caudal 
regions of the mesencephalon, where neural crest migration 
is just beginning, have the greatest sensitivity to the injected 
antibody. 
In a  few of the experimental embryos, those neural crest 
cells present on the injected side migrated along an aberrant 
pathway; instead of moving laterally under the ectoderm the 
cells migrated along the  ventral portion  of the  neural  tube 
and through the  mesenchyme. In  7  of the 41  embryos, no 
alterations in neural crest migration were apparent. In these 
cases,  it  is  possible that  the  antibody was diluted  through 
leakage out of  the puncture hole made by the injection needle. 
Effects of 7-B and 1-N Antibodies on Cranial 
Neural Crest Migration 
A possible complication of the antibody injection approach 
FIGURE  3  Fluorescence photomicrographs of embryos fixed  11  h 
after  injection  of  JG22  antibodies  and  hybridoma  cells  into  the 
mesencephalon. The sections were stained with HNK-1  antibodies 
to recognize neural crest cells. Neural crest cells in the mesenceph- 
alon normally emigrate away from the neural tube (nt)  and into the 
mesenchyme just beneath the ectoderm. (a) A  section through the 
main  injection  site,  containing  the  highest  concentration  of  hy- 
bridoma cells, x  330. The brightly fluorescent hybridoma cells that 
were  labeled  with  CFSE before  injection  are  easily  seen  on  the 
right-hand  side  (indicated by the arrow).  In the  presence of JG22 
antibodies, the  number of neural crest  cells  on the  injected  side 
was  markedly reduced.  Quantitative  reconstruction  of serial  sec- 
tions  throughout  the  mesencephalon  of  this  particular  embryo 
demonstrated a 51% reduction  in neural crest cell volume on the 
injected  side  relative  to  the  control  side.  (b)  Another  section 
through  the  posterior mesencephalon of the  same  embryo  illus- 
trated  in  a.  x  330.  The  reduction  in  neural  crest  cell  number  is 
more severe and the cells have not migrated as far ventrally on the 
injected  side.  In addition,  a  Iobule  has formed  within  the  neural 
tube  (nt)  which  contains  neural  crest  cells  (identified  by  HNK-1 
staining). (c)  Another embryo at  higher magnification with  a  pro- 
found  build  up  of  neural  crest  cells  (nc)  in  the  lumen  of  the 
mesencephalic neural tube. x  1,200. 
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duced by an antibody may be unrelated to a functional block 
of the antigen it recognizes. To control for such a possibility, 
the  experiments  described  above  were  repeated  using  two 
different hybridomas clones,  1-B or l-N, instead  of JG22.  1- 
B and  I-N cells produce antibodies that recognize bands  1 
and 3, respectively, of the complex precipitated by JG22 and 
CSAT (Buck, C., personal communication), but unlike JG22 
and CSAT do not alter cell adhesion. In tissue culture, neither 
1-B or 1-N antibodies caused detachment of neural crest cells. 
After the injection of 1-B (n  =  14 embryos) or  1-N (n  =  8 
embryos) hybridoma cells and concentrated antibody solution 
into the mesencephalic region,  no inhibition of neural crest 
migration  and  no build-up of neural  crest  ceils  within  the 
dorsal neural tube was observed (Fig. 4). The volume occupied 
by neural crest  cells on both the injected  and control sides 
was quantitated in serial  sections through six representative 
embryos. The volume on the side  injected  with hybridoma 
cells was  102 +  8%  of that on the control side for I-B, and 
98  _+ 7%  for the  I-N antibody. The reduction for embryos 
injected with JG22 hybridoma ceils was 54%. Thus, introduc- 
tion  of lgG's  and  hybridoma cells  that  do  not  block  the 
function of the  140-kD complex had no noticeable effect on 
the distribution of neural crest cells. These results suggest that 
the alterations in neural crest migration caused by JG22 result 
from a functional block of the  140-kD complex. 
Effects of JC22 Antibody on Trunk 
Neural Crest Migration 
To examine the affects of JG22 antibody on neural crest 
migration  in  the  trunk,  JG22  antibodies  and  labeled  hy- 
bridoma cells were injected  into the trunk somites.  Injections 
were made -10 somites anterior to the most recently formed 
somite.  This is a level where endogenous neural crest cells are 
just  beginning to penetrate  the  anterior part of the  somite 
after the somite dissociates  into the dermatome, myotome, 
and sclerotome (Rickmann, R.,  J.  Fawcett,  and R.  Keynes, 
manuscript in preparation; Bronner-Fraser, M.,  manuscript 
submitted for publication). Approximately 0.5 nl was injected 
into each somite.  Embryos were fixed and processed  from 7 
to 21 h after the initial  injection. 
As observed in  the  cranial  region,  a  separation  between 
injected  JG22  hybridoma ceils  and  neural  crest  cells  was 
observed in the trunk. Other effects of JG22 on trunk neural 
crest  migration were  variable.  Seven  of the 28  embryos ex- 
amined did have a decreased  volume of neural crest cells on 
the injected side, though to a lesser extent than noted in the 
mesencephalon. A  15% reduction in neural crest cell volume 
on the injected side relative to the control side was determined 
by quantitative reconstruction of one representative  embryo. 
In  another two  embryos,  neural  crest  cells  were  observed 
migrating along aberrant pathways.  In these cases, crest cells 
were seen invading the region around the notochord, or were 
seen  within the myotome. In normal embryos, neural crest 
cells avoid the space around the notochord and do not pene- 
trate the myotome (19). In  19 of the 28 embryos examined, 
no marked differences in neural crest migration were observed 
on the injected side relative to the control side. 
DISCUSSION 
This  study examines  the  effects  of the  JG22  antibody on 
neural crest cell adhesion in tissue culture and in the embryo. 
FIGURE  4  Fluorescence  photomicrographs of  a  control  embryo 
fixed  11  h after injection of  1-N  hybridoma cells  and antibodies 
into the  mesencephalon. The sections  were stained with  HNK-1 
antibodies to recognize neural crest cells. (a}  A section through the 
main  injection site  containing the  highest  concentration  of  hy- 
bridoma cells, indicated by the arrow, x  260. (b)  Another section 
through the  posterior mesencephalon of the same embryo illus- 
trated in a. x  260. After injection of control hydridoma cells and 
antibodies, no differences in the number of neural crest cells were 
noted between the injected side and the control side. Quantitative 
reconstruction of serial sections throughout the mesencephalon of 
this  particular  embryo  demonstrated that  the  neural  crest  cell 
volume on the injected side was 96% of that on the control side. 
In contrast, embryos injected with JG22 antibodies and hybridoma 
cells had a 50% reduction in neural crest cell volume (compare Fig. 
3). nt, neural tube. 
The antibody, originally found to perturb adhesion of skeletal 
muscle  cells in vitro (11), was discovered to cause  rounding 
and detachment of  neural crest cells plated on both fibronectin 
and laminin tissue  culture substrates.  Control antibodies (1- 
B  and  I-N)  that  bind  to  bands  of the  140-kD  complex 
precipitated  by JG22  (Buck,  C.,  personal  communication) 
had no affect on neural crest cell adhesion.  In frozen sections 
of young chick embryos, the JG22 antigen is present on the 
surface  of neural crest  cells and  is also  found on the basal 
surface  of the  neural  tube,  myotome, and  notochord. The 
latter  tissues,  however,  were  not  affected  in  vitro  by  the 
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To examine the effects of this antibody on neural crest cells 
in vivo, a new approach for perturbing embryonic cell migra- 
tion was developed. JG22 antibodies together with  the hy- 
bridoma cells were microinjected onto neural crest pathways. 
The hybridoma cells were stained with a long-lasting fluores- 
cent marker that is nondeleterious and has the advantage of 
being detectable in  fixed  histological  sections.  The labeled 
hybridoma cells serve both as markers for the exact locus of 
the  injection  site and  as  a  continuous  source of antibody. 
When  JG22  antibodies and  hybridoma cells were microin- 
jected into the mesencephalic neural crest pathway, the fol- 
lowing changes were observed: (a) neural crest migration was 
reduced in  83%  of the injected embryos; (b) a  build-up of 
neural crest cells within the lumen of the neural tube occured 
in 26% of the affected embryos; (c) neural crest cells migrated 
along aberrant pathways in 6% of the affected embyros; and 
(d) a space of one or more cell diameters was seen between 
the neural crest cells and most of the JG22 hybridoma cells 
in  all  injected embryos. Control  injections performed with 
the  I-B or I-N antibodies and hybridoma cells did not cause 
alterations in neural crest migration. These findings suggest 
that the observed effects are caused by functional block of the 
140-kD complex recognized by JG22. In the the trunk region, 
the effects of JG22 were far less reproducible and consistent 
for the antibody tiLer and injected volumes used in this study. 
In a few cases, the numbers of neural crest cells were some- 
what reduced, and  in  other cases, the crest cells moved in 
aberrant directions to invade the perinotochordal space and 
the myotome. Normally, no crest cells are seen within these 
spaces (Bronner-Fraser, M., manuscript submitted for publi- 
cation; 19). 
A quantitation  of neural crest cell volume of the injected 
side relative to the noninjected side of the embryos demon- 
strated a 50% reduction of cranial neural crest cell migration 
after injection of JG22 antibodies; no reduction was observed 
in control embryos injected with  I-B or 1-N antibodies and 
hybridoma cells. The serial reconstructions used in this study 
demonstrate that simple quantitation can provide useful in- 
formation in systems as complicated as neural crest migration. 
Such methods provide a global picture of the effects produced 
by perturbation techniques.  In contrast, examination of in- 
dividual sections may prove misleading since no section can 
be truly  representative and  the  effects may be  masked or 
amplified by the exact plane of section. 
Several possible explanations may account for the apparent 
reduction in the number of neural crest cells after injection 
of JG22. For example, the antibody may diminish the ability 
of neural crest cells to emigrate from the neural tube. In the 
absence of compensatory hyperplasia, this would result in a 
decrease  in  the  total  number  of neural  crest  cells  on  the 
injected  side.  In support  of this  idea,  JG22  often  led  to  a 
build-up of neural crest cells within the lumen of the neural 
tube.  Alternatively, JG22  may affect the  neural  crest  cells 
only after their departure from the neural tube, by altering 
either  their  ability  to  proliferate  or  their  survival.  Future 
experiments that examine the effects of JG22 on neural crest 
cells in vitro may distinguish among these alternatives. 
The results indicate that the cell surface antigen recognized 
by JG22 is important for the normal migration of neural crest 
cells in the cranial region since the amount of neural crest 
migration is reduced in the presence of the antibody. Neural 
crest migratory routes in the mesencephalon are rich in fibro- 
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nectin  (10).  Therefore,  it  is  likely that  JG22  perturbs  the 
normal adhesion  of neural  crest  cells  to  a  fibronectin-rich 
matrix and that this adhesion  is important for normal cell 
migration. It is interesting that a similar inhibition of neural 
crest migration was observed by Boucaut  et al.  (2)  after a 
synthetic decapeptide that appears to contain the cell recog- 
nition sequence of fibronectin (21,  27) was injected into the 
mesencephalic neural crest pathway. These investigators ob- 
served a bilateral reduction in numbers of cranial neural crest 
cells and a build-up of neural crest cells within the lumen of 
the neural  tube (2).  Presumably, both the decapeptide and 
the JG22 antibody alter the adhesion of neural crest cells to 
fibronectin. Support for this idea comes from a recent study 
on  chick  embryo fibroblasts,  which  demonstrates that  the 
JG22 antigen co-distributes with extracellular fibronectin and 
intraceUular a-actinin (6). It is surprising that JG22 also affects 
adhesion  of neural  crest cells to  laminin-coated substrates, 
which suggests  that the  140-kD complex may not be com- 
pletely specific for flbronectin.  Studies  that  show  that  the 
JG22 antigen is present on the basolateral membrane surface 
of the intestinal epithelium (5) suggest that the 140-kD com- 
plex may be associated with laminin in situ.  In contrast to 
JG22,  the synthetic peptides containing the fibronectin cell 
recognition  site  do  not  appear  to  affect  cell  adhesion  to 
laminin substrates. 
Fibronectin is present in both the trunk and cranial regions 
of the embryo during neural crest migration (10,  24). At the 
concentrations used in this study, the effects of  JG22 antibody 
in the trunk were less dramatic than those observed in the 
cranial region, even though the antibody and hybridoma cells 
were injected into  regions of active neural  crest migration. 
This may result from the fact that a much smaller volume of 
antibody can be conveniently introduced into the trunk com- 
pared to the cranial regions. The smaller volume occupied by 
neural crest cells in the trunk might be expected to partially 
compensate for the smaller injection volume; however, the 
results show that the trunk injections are less effective. Perhaps 
the smaller injected volume leads to a  greater proportional 
leakage of antibody out of the injection site, thereby lowering 
the effective antibody concentrations. In addition, the tissues 
surrounding the injection site may absorb more JG22 anti- 
body  in  the  trunk  than  in  the  cranial  region  leaving  less 
antibody free to interact with the neural crest cells. Another 
possible and more intriguing explanation is that the extracel- 
lular matrix may be different or more complex in the trunk 
than  in  cranial  regions.  Though  neural  crest  cells  in  the 
mesencephalon seem to follow flbronectin-rich pathways, re- 
cent studies indicate that most neural crest cells in the trunk 
migrate through the anterior portion of each somite, which 
contains little or no flbronectin (Rickmann, R., J.  Fawcett, 
and  R.  Keynes, manuscript in preparation).  If neural crest 
cells migrate along ECMs, additional species of matrix mole- 
cules must be present in the trunk. Thus, the adhesive inter- 
actions perturbed  by JG22  may not  be the  dominant  cell 
surface-ECM interaction involved in trunk neural crest mi- 
gration. We are currently examining these different possibili- 
ties. 
It is interesting to note that a  number of embryonic cell 
types including  the  neural  tube,  notochord,  and  myotome 
have the JG22 antigen on their surface; however, the adhesion 
of these cells to tissue culture substrates is not perturbed in 
the  presence  of antibody.  Decker et  al.  (9)  have  reported 
similar findings using the CSAT antibody. They detected the 140-kD complex on the surface of skeletal and cardiac muscle 
as well as on tendon, skeletal, dermal, and cardiac fibroblasts. 
In  contrast,  the  antibody  caused  detectable  morphological 
changes only on skeletal muscle and cardiac fibroblasts. They 
suggest that there may be an adhesive hierarchy in different 
cell  types  with  the  CSAT/JG22  antigen  appearing  as  the 
lowest common denominator. This idea receives support from 
the fnding that JG22 antibody prevents the initial adhesion 
of chick embryo fibroblasts to fibronectin  substrates (6) but 
does not affect cell morphology when added after cell attach- 
ment and spreading have taken place. 
The  present  study describes a  new antibody perturbation 
technique  in  which  both the  antibody and  hybridoma cells 
are introduced into embryos. This perturbation approach may 
be  generally  applicable  in  studies  elucidating  the  roles  of 
certain antigens in early embryogenesis. In this article a novel 
cell  labeling  technique  is  also described  which  allows long- 
term identification  of implanted cells.  This labeling method 
may provide a generally useful marker for intra- and interspe- 
cific grafts (Bronner-Fraser,  M., and S. Fraser,  manuscript in 
preparation),  as  well  as  for  in  vitro  experiments  in  which 
differentially labeled tissues are brought into contact. By use 
of this  approach,  the  antibody  JG22  was  found  to  cause 
profound alterations  in  cranial  neural  crest  migration.  This 
probably results from the binding and functional inactivation 
by JG22 of a cell surface complex involved in recognition of 
fibronectin (6). The results suggest that this cell surface mol- 
ecule  may be important for normal cranial  neural crest mi- 
gration. The results on neural crest migration are too incom- 
plete to support the naive suggestion that interactions between 
a  single  cell  surface  component and an  ECM  molecule  are 
uniquely responsible for the guidance of a complex develop- 
mental  process such  as neural  crest  migration.  Rather,  the 
data  remain  consistent  with  the  presence  of a  number  of 
molecules;  these may function  synergistically such that per- 
turbation  of one  or more  of their  interactions  would  alter 
normal morphogenesis. 
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NoteAdded in Proof."  Since this manuscript went to press, analogous 
experiments were performed using CSAT ( 16; kindly provided by Dr. 
C.  Buck), which binds to the same  140-kD complex recognized by 
JG22. The preliminary results suggest that CSAT causes alterations 
in  neural crest adhesion  in  vitro and  migration in  vivo similar to 
those observed after exposure to JG22. 
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